This is a monumental stuff-up and some heads should roll for sure. Having said this, it is a spec stock so the ultimate value of the stock will be realised when they have product approval and the sp goes through the roof or when the trials fail and it becomes worthless. To that extent, nothing has changed. This is very bad for short term investors but really makes no difference to those of us here for the long haul. Very depressing in the short term though.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $2.114B | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.64 | $5.790M | 3.482M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 460 | $1.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 67181 | 6 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |